COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
Microorganisms · 19.11.2025 · 13 (11) · 2622
DOI: 10.3390/microorganisms13112622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 19.11.2025. Verfasst von Amani Bouabdallah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine of Tunis, University of Tunis El Manar, Jebbari, Tunis 1007, Tunisia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education and Scientific Research of Tunisia.
Abstract (Originalsprache)
Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine of Tunis, University of Tunis El Manar, Jebbari, Tunis 1007, Tunisia.
- Laboratory of Biochemistry, Rabta Hospital, LR99ES11, Jebbari, Tunis 1007, Tunisia.
- Service of Infectious Diseases, Rabta Hospital, Jebbari, Tunis 1007, Tunisia.
- Department of Infectious Diseases and Tropical Medicine, Hôpital Nord-Franche-Comté, 90400 Belfort-Montbéliard, France.
- Clinical Research Unit, Hôpital Nord-Franche-Comté, 90400 Belfort-Montbéliard, France.
ORCID-Profile: Amani Bouabdallah, Mohamed Bessem Hammami, Timothée Klopfenstein, Moncef Feki
Förderung
- Ministry of Higher Education and Scientific Research of Tunisia
Zitieren
APA
Bouabdallah, A., Ben-Fradj, M. K., Hammami, M. B., Abdelmalek, R., Sanhaji, H., Klopfenstein, T., & Feki, M. (2025). COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia. Microorganisms, 13(11), 2622. https://doi.org/10.3390/microorganisms13112622
Vancouver
Bouabdallah A, Ben-Fradj MK, Hammami MB, Abdelmalek R, Sanhaji H, Klopfenstein T, et al. COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia. Microorganisms. 2025;13(11):2622. doi:10.3390/microorganisms13112622
BibTeX
@article{Bouabdallah2025,
author = {Bouabdallah, Amani and Ben-Fradj, Mohamed Kacem and Hammami, Mohamed Bessem and Abdelmalek, Rim and Sanhaji, Haifa and Klopfenstein, Timothée and Feki, Moncef},
title = {COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {11},
pages = {2622},
doi = {10.3390/microorganisms13112622}
}
EUVIMED